Search | IOVS | ARVO Journals

Showing 1 – 20 of 143

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Articles February 2021

Genome-Wide Association Studies-Based Machine Learning for Prediction of Age-Related Macular Degeneration Risk

PDF

Qi Yan; Yale Jiang; Heng Huang; Anand Swaroop; Emily Y. Chew; Daniel E. Weeks; Wei Chen; Ying Ding
TAGS: age-related macular degeneration, genome, genome-wide association study, machine learning, single nucleotide polymorphism, datasets, genotype
Trans. Vis. Sci. Tech.. 2021; 10(2):29. doi: https://doi.org/10.1167/tvst.10.2.29

Includes: Supplemental Content

Retina June 2020

Macular Thickness in Intermediate Age-Related Macular Degeneration Is Influenced by Disease Severity and Subretinal Drusenoid Deposit Presence

PDF

Trent Tsun-Kang Chiang; Tiarnan D. Keenan; Elvira Agrón; Jennifer Liao; Brandon Klein; Emily Y. Chew; Catherine A. Cukras; Wai T. Wong
TAGS: age-related macular degeneration, digestive tract decontamination, eye, severity of illness, drusen
Invest. Ophthalmol. Vis. Sci.. 2020; 61(6):59. doi: https://doi.org/10.1167/iovs.61.6.59

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Association of short-term progression in AMD score with risk of development of late AMD and vision loss in the AREDS2 study

Susan Vitale; Elvira Agron; Traci E Clemons; Amitha Domalpally; Ronald P Danis; Tiarnan D L Keenan; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):52. doi:

ARVO Annual Meeting Abstract July 2019

Development of Outcome Measurements for Studies of Macular Telangiectasia (Mac Tel) Type 2

Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):994. doi:

ARVO Annual Meeting Abstract July 2019

Repeatability and Comparison of Dark Adaptation Using the Medmont DAC Perimeter and AdaptDx Dark Adaptometer

Durin Yesmin Uddin; Brett Jeffrey; Wai T Wong; Henry Ernest Wiley; Tiarnan D L Keenan; Oliver J Flynn; Emily Y Chew; Catherine A Cukras

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1137. doi:

ARVO Annual Meeting Abstract July 2019

Charles Bonnet Syndrome in Participants of the Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-on

Elvira Agron; Emily Y Chew; Tiarnan D L Keenan; Traci E Clemons

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1173. doi:

ARVO Annual Meeting Abstract July 2019

Macular thinning occurs in Non-Advanced Age-related Macular Degeneration (AMD) and varies with AMD Stage and Subretinal Drusenoid Deposit (SDD) Presence

TsunKang "Trent" Chiang; Tiarnan D L Keenan; Jennifer Liao; Brandon Klein; Emily Y Chew; Catherine A Cukras; Wai T Wong

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1182. doi:

ARVO Annual Meeting Abstract July 2019

Characteristics of Reticular Pseudodrusen in the AREDS2

Meghana Agni; Jeong W Pak; Amitha Domalpally; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1188. doi:

ARVO Annual Meeting Abstract July 2019

Genetic factors associated with reticular pseudodrusen in participants of the Age-Related Eye Disease Study 2 (AREDS2)

Christopher Hwang; Elvira Agron; Traci E Clemons; Tiarnan D L Keenan; Catherine A Cukras; Wai T Wong; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1194. doi:

ARVO Annual Meeting Abstract July 2019

Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment

Jessica Loo; Traci E Clemons; Emily Y Chew; Martin Friedlander; Glenn J Jaffe; Sina Farsiu

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1449. doi:

ARVO Annual Meeting Abstract July 2019

Classification of Intermediate Age-Related Macular Degeneration by Short-Term Risk for Atrophy on Spectral Domain Optical Coherence Tomography

Eleonora M Lad; Karim Sleiman; David L Banks; Sanjay Hariharan; Traci E Clemons; Emily Y Chew; Cynthia A Toth

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2213. doi:

ARVO Annual Meeting Abstract July 2019

Reticular Pseudodrusen as a Risk Factor for Progression of Age-related Macular Degeneration

Amitha Domalpally; Jeong W Pak; Elvira Agron; Traci E Clemons; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2216. doi:

ARVO Annual Meeting Abstract July 2019

Ocular findings in a phase 2 trial testing the first-in-class oral HIF-2α inhibitor, PT2385, for renal cell carcinoma in von Hippel-Lindau disease

Henry Wiley; Ramaprasad Srinivasan; Marston Linehan; Catherine A Cukras; Tiarnan D L Keenan; Wai T Wong; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2782. doi:

ARVO Annual Meeting Abstract July 2019

Beyond GWAS: Functional genomics of age-related macular degeneration

Anand Swaroop; Freekje Van Asten; Madeline Kwiklis; Kayode Sosina; Margaret Starostik; Nivedita Singh; Dena Hernandez; Emily Y Chew; Andrew Singleton; Alexis Battle; Deb A Ferrington; Nilanjan Chatterjee; Rinki Ratnapriya

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4246. doi:

ARVO Annual Meeting Abstract July 2019

Blue-light reflectance imaging in macular telangiectasia type 2 (MacTel) using two different SLO systems.

Ferenc B Sallo; Vincent Rocco; Irene Leung; Adam M Dubis; Ute EK Wolf-Schnurrbusch; Catherine A Egan; Tunde Peto; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5049. doi:

ARVO Annual Meeting Abstract July 2019

Comparison of Choroidal and Retinal Thicknesses in Patients With and Without Hydroxychloroquine Toxicity.

Munir Iqbal; Wai T Wong; Emily Y Chew; Catherine A Cukras

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5715. doi:

ARVO Annual Meeting Abstract July 2019

Visual acuity outcomes of cataract surgery in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study

Debora Hana Lee; Elvira Agron; Tiarnan D L Keenan; Craig M Greven; Ronald P Danis; James F Lovato; Walter T Ambrosius; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2067. doi:

ARVO Annual Meeting Abstract July 2019

EPAS1 gain-of-function mutation causes ocular manifestations in HIF-2α paraganglioma-somatostatinoma-polycythemia syndrome

Pauline Dmitriev; Herui Wang; Karel Pacak; Emily Y Chew; Zhengping Zhuang

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2938. doi:

ARVO Annual Meeting Abstract July 2019

Deep learning prediction of progression to late age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) using deep feature extraction and survival analysis

Tiarnan D L Keenan; Yifan Peng; Qingyu Chen; Elvira Agron; Wai T Wong; Zhiyong Lu; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1491. doi:

ARVO Annual Meeting Abstract July 2019

A New Classification for Macular Telangiectasia type 2 based on multi-modal imaging

Emily Y Chew; Tunde Peto; Traci E Clemons; Daniel Pauleikhoff; Ferenc B Sallo; Tjebo Heeren; Catherine A Egan; Peter Charbel Issa; Konstatinos Balaskas; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1335. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Genome-Wide Association Studies-Based Machine Learning for Prediction of Age-Related Macular Degeneration Risk

Macular Thickness in Intermediate Age-Related Macular Degeneration Is Influenced by Disease Severity and Subretinal Drusenoid Deposit Presence

Association of short-term progression in AMD score with risk of development of late AMD and vision loss in the AREDS2 study

Development of Outcome Measurements for Studies of Macular Telangiectasia (Mac Tel) Type 2

Repeatability and Comparison of Dark Adaptation Using the Medmont DAC Perimeter and AdaptDx Dark Adaptometer

Charles Bonnet Syndrome in Participants of the Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-on

Macular thinning occurs in Non-Advanced Age-related Macular Degeneration (AMD) and varies with AMD Stage and Subretinal Drusenoid Deposit (SDD) Presence

Characteristics of Reticular Pseudodrusen in the AREDS2

Genetic factors associated with reticular pseudodrusen in participants of the Age-Related Eye Disease Study 2 (AREDS2)

Automatic Deep Learning OCT Analysis Algorithm Reliably Reproduces Expert-Evaluated Outcome of a Randomized Clinical Trial for Macular Telangiectasia Type 2 Treatment

Classification of Intermediate Age-Related Macular Degeneration by Short-Term Risk for Atrophy on Spectral Domain Optical Coherence Tomography

Reticular Pseudodrusen as a Risk Factor for Progression of Age-related Macular Degeneration

Ocular findings in a phase 2 trial testing the first-in-class oral HIF-2α inhibitor, PT2385, for renal cell carcinoma in von Hippel-Lindau disease

Beyond GWAS: Functional genomics of age-related macular degeneration

Blue-light reflectance imaging in macular telangiectasia type 2 (MacTel) using two different SLO systems.

Comparison of Choroidal and Retinal Thicknesses in Patients With and Without Hydroxychloroquine Toxicity.

Visual acuity outcomes of cataract surgery in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study

EPAS1 gain-of-function mutation causes ocular manifestations in HIF-2α paraganglioma-somatostatinoma-polycythemia syndrome

Deep learning prediction of progression to late age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) using deep feature extraction and survival analysis

A New Classification for Macular Telangiectasia type 2 based on multi-modal imaging

To View More...

You must be signed into an individual account to use this feature.